References
- Gray A, Matsebula T, Blaauw D, Schneider H, Gilson L. Policy change in a context of transition: Drug policy in South Africa, 1989–1999. Cent heal policy, Univ Witwatersrand 2002; Available from: http://researchonline.lshtm.ac.uk/id/eprint/14225.
- National Department of Health South Africa. National Drug Policy for South Africa. National Department of Health. Pretoria; 1996. Available from: https://www.gov.za/sites/default/files/gcis_document/201409/drugpol0.pdf.
- Digby A. Black doctors and discrimination under South africa’s apartheid regime. Med Hist. 2013;57:269–290.
- Republic of South Africa. Debate of the National Assembly First Session- Second Parliament 4th February to 26 November. Cape Town: Government Printers; 1997. p. 5391–5442.
- Department of Rural Development and Land Reform South Africa. Draft National Spatial Development Framework. 2018.
- Ward K, Sanders D, Leng H, Pollock AM. Assessing equity in the geographical distribution of community pharmacies in South Africa in preparation for a national health insurance scheme. Bull World Health Organ. 2014;92:482–489.
- Republic of South Africa. Local Government: Municipal Structures Act, 1998 (Act No 117 of 1998) GNR 19614 18 December 1998. 1998. Available from: http://www.gov.za/sites/www.gov.za/files/a117-98_0.pdf.
- National Department of Health South Africa. Regulations relating to the Ownership and Licencing of Pharmacies GNR.553 25th April 2003. 2003.
- Lowe RF, Montagu D. Legislation, regulation, and consolidation in the retail pharmacy sector in low income countries. South Med Rev. 2009;2:35–44 Available from: http://apps.who.int/medicinedocs/documents/s16382e/s16382e.pdf.
- Vogler S, Danielle A, Habl C. Community pharmacy in Europe: Lessons from deregulation – case studies. Austrian Health Institute, for Pharmaceutic Group of the European Union. Vienna, February 2006. Available from: https://www.actasanitaria.com/fileset/doc_20719_FICHERO_NOTICIA_6431.pdf.
- International Pharmaceutical Federation. Ownership of Community Pharmacies -Models and Policy Options. The Hague; 2016.
- Barbarisi I, Bruno G, Diglio A, Elizalde J, Piccolo C. A spatial analysis to evaluate the impact of deregulation policies in the pharmacy sector: evidence from the case of Navarre. Health Policy. 2019;123:1108–1115. Available from. https://doi.org/10.1016/j.healthpol.2019.08.010.
- Wisell K, Winblad U, Sporrong SK. Reregulation of the Swedish pharmacy sector-a qualitative content analysis of the political rationale. Health Policy. 2015;119:648–653. Available from. https://doi.org/10.1016/j.healthpol.2015.03.009.
- Burton S, Kubashe N. Corporatization of Community Pharmacy. Encycl Pharm Pract Clin Pharm. 2019;2:278–88.
- O’Shea T. 6 Surprising Pharmacy Laws. Pharm Times [Internet]. 2015. Available from: https://www.pharmacytimes.com/contributor/timothy-o-shea/2015/07/6-surprising-pharmacy-laws.
- LaVecchia O, Mitchell S. North Dakota’s pharmacy ownership law. 2014. Available from: https://ilsr.org/wp-content/uploads/2014/10/ND_Pharmacy_Ownership_Report.pdf.
- Medpages. The Medpages Database. [cited 2019 Oct 1]. Available from: https://www.medpages.info/sf/index.php?page=stats&countryid=1.
- Statistics South Africa. stats sa. Stat. RELEASE- Popul. 2016.
- Municipal Demarcation Board. MDB Local Municipal Boundary. Spat. Hub: Knowl; 2018.
- Municiple Demarcation Board. Municipal Demarcation Board. 2020. Available from: http://www.demarcation.org.za/site/?page_id=1394.
- Massyn N, Padarath A, Peer N, Candy D. District Health Barometer 2016/17. Health Systems Trust; 2017.
- Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy. 2005;75:9–17.
- Azzopardi LM. Pharmacy Practice in Western Europe. Encycl Pharm Pract Clin Pharm. 2019;1:478–87.
- Gray A, Riddin J, Jugathpal J. Health care and pharmacy practice in South Africa. Can J Hosp Pharm. 2016;69:36–41. Available from: http://www.cjhp-online.ca/index.php/cjhp/article/view/1521.
- Vogler S, Habimana K, Arts D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy. 2014;117:311–327. Available from:. https://doi.org/10.1016/j.healthpol.2014.06.001.
- Vogler S, Zimmermann N, Leopold C, de Joncheere K. Pharmaceutical policies in European countries in response to the global financial crisis. South Med Rev. 2011;4:22–32 Available from: http://apps.who.int/medicinedocs/documents/s19046en/s19046en.pdf.
- Lluch M, Kanavos P. Impact of regulation of community pharmacies on efficiency, access and equity. Evidence from the UK and Spain. Health Policy. 2010;95:245–254. Available from:. https://doi.org/10.1016/j.healthpol.2009.11.002.
- Strasser R. Rural Health Research: Have we Turned the Corner? Aust J Rural Health. 2000;8:249–253. Available from:. https://doi.org/10.1046/j.1440-1584.2000.00334.x.
- Philipsen NJ. Regulation of pharmacists: a comparative law and economics analysis. SSRN Electron J. 2014;10:225–241. Available from: http://www.ssrn.com/abstract=2512267.
- Massyn N, Peer N, English R, Padarath A, Barron P, Candy D. District Health Barometer 2015/16. Health Systems Trust. Durban; 2016.